GlassScriptPhysician profile
Rutvij J Shah
NPI 1306209903
$86,403.63
in general payments reported to CMS, 2019-2025
31 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $5,467 · 2021: $2,046 · 2022: $7,301 · 2023: $11K · 2024: $14K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $13K · Food and Beverage: $5,439 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,633 · Education: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,825.00 |
| Travel and Lodging | $12,568.83 |
| Food and Beverage | $5,438.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,632.50 |
| Education | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $54,731.38 | 2021-2025 | Mild Device Kit, Spinejack, Augment Injectable |
| Medtronic, INC. | $10,389.13 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Activos 10 Bone Cement |
| Spinal Simplicity, LLC | $6,605.39 | 2021-2023 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $5,000.00 | 2020 | |
| Boston Scientific Corporation | $2,439.06 | 2020-2025 | Wavewriter Alpha Prime 16, Accolade Sr, Intracept |
| Painteq LLC | $1,517.80 | 2022 | |
| Relievant Medsystems, INC. | $1,407.56 | 2022-2023 | Intracept |
| Abbott Laboratories | $767.75 | 2021-2025 | Proclaim, Eterna |
| Genesys Orthopedics Systems, L.L.C. | $733.36 | 2022 | |
| Nevro Corp. | $619.45 | 2021-2024 | Senza |
| Abbvie INC. | $417.41 | 2021-2025 | Ubrelvy |
| Surgentec | $319.41 | 2021 | |
| Allergan, INC. | $258.16 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $248.81 | 2019-2020 | |
| Curonix LLC | $221.54 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $191.68 | 2022-2024 | Sprint Pns System |
| Vertos Medical, INC. | $114.91 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $65.76 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $45.21 | 2021 | |
| Avanos Medical | $45.15 | 2021-2025 | Needles - All |
| Eisai INC. | $38.89 | 2022 | |
| Merck Sharp & Dohme LLC | $32.18 | 2023-2024 | Keytruda, Bridion |
| Genzyme Corporation | $31.51 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $30.07 | 2022 | |
| Tersera Therapeutics LLC | $23.38 | 2023 | Prialt |
| Edwards Lifesciences Corporation | $23.17 | 2021 | |
| Tonix Medicines, INC. | $22.01 | 2025 | Tonmya |
| Emd Serono, INC. | $18.41 | 2020 | |
| Seagen INC. | $16.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2023 | |
| Merit Medical Systems INC | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rutvij Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.